Introduction
The p16 INK4A and p19 ARF cell cycle inhibitors are encoded by alternative exons of the INK4A gene locus on chromosome 9p21.
1,2 Inactivation of INK4A frequently occurs (B80%) in primary tumor cells of T-cell acute lymphoblastic leukemia (T-ALL), suggesting a critical role of this locus in disease development. [3] [4] [5] The importance of this gene locus is also supported by the observation that spontaneous lymphomas are common in INK4A knockout mice, 6 and that the loss of INK4A predicts relapse in children with ALL. 7, 8 p16
INK4A binds to and inhibits the activity of the cyclin Ddependent kinases CDK4 and CDK6, which are critical for G1 progression and G1/S transition. The activity of these serine/ threonine protein kinases is further regulated by mitogenic hormones, by additional INK4 inhibitors and by p21 Cip1 , p27 Kip1 and p57 Kip2 . 9, 10 Active CDK4/6 complexes phosphorylate and inactivate pRB and its family members p107 and p130, thus promoting the activity of E2F-transcription factors and the expression of genes essential for the onset of S-phase and mitosis. 11 The proto-oncogene c-Myc is part of a transcriptional regulatory network that contributes significantly to G1/S transition, 12 although it is apparently not essential for cell cycle progression. 13 c-Myc is regulated by mitogenic hormones and controls growth and promotes progression through the cell cycle by transcriptional induction of D-type cyclins, 14 cyclin E 15 and cyclin A. 16 It stimulates cyclin E/CDK2 activity and S-phase entry by abrogating p27
Kip1 inhibition either by redistribution of this inhibitor to cyclin D/CDK4, 17, 18 or by increased degradation via the ubiquitin-ligase complex SCF SKP2 . 19 Expression of transgenic cyclin E and transgenic c-Myc have been shown to bypass the growth inhibitory effect of p16 INK4A in rodent fibroblasts. 20 Expression of a conditional p16
INK4A allele in CCRF-CEM acute lymphoblastic T-cells caused cell cycle arrest, which was associated with elevated glucocorticoid receptor expression and increased sensitivity to glucocorticoid-induced apoptosis. 21 In the present study, we further characterized the molecular mechanisms leading to p16
INK4A -induced cell cycle arrest and studied the effects of protracted p16
INK4A expression on the physiology of this childhood ALL model.
Results

Tetracycline-regulated p16
INK4A expression in stably transfected CCRF-CEM ALL cells (that lack endogenous p16 INK4A due to a homozygous deletion of the INK4A gene locus 22, 23 ) induced cell cycle arrest (Figure 1a ) that did not alter viability up to 72 h after addition of doxycycline. 21 Thereafter, however, the cells started to undergo spontaneous apoptosis (Figure 1b) . In the parental cell line CCRF-CEM-C7H2-2C8, doxycycline did not detectably affect cell cycle progression or viability. To further delineate the molecular mechanism leading to cell cycle arrest and delayed apoptosis in this system, we analyzed the expression and functional activity of several G1/S transition-regulating proteins.
Transgenic p16
INK4A causes hypophosphorylation of pRB and repression of E2F regulated target genes, but does not affect cyclin E, CDK2 or c-Myc expression
Induction of p16
INK4A in CCRF-CEM T-ALL cells prevented phosphorylation of pRB, as suggested by the appearance of the hypophosphorylated, faster migrating form of pRB (Figure 2a) . Transcriptional downstream targets such as E2F-1 and DHFR were markedly repressed, (Figure 2b ), which is in agreement with pRB activation, whereas c-myc mRNA was not downregulated. As GAPDH, which served as a loading control was also affected by p16
INK4A expression, we further used a probe directed against 18S RNA. Our data support the notion that the pRB-E2F1 pathway is functional in these cells but deregulated due to homozygous deletion of p16 INK4A . The expression of c-Myc, cyclin E and CDK2 was not affected by p16 INK4A expression (Figure 2a) , which was surprising since p16
INK4A is believed to act upstream of c-Myc and cyclin E, 20 thus raising the question of how p16
INK4A might cause cell cycle arrest in the presence of high levels of c-Myc and cyclin E. p16
INK4A induces accumulation, stabilization and redistribution of p27
Kip1 from CDK4 and CDK6 to CDK2, leading to repression of cyclin E/CDK2 kinase activity. Time-course studies revealed that the hypophosphorylated form of pRB first appeared as early as 6 h after induction of transgenic p16 INK4A . At 24 and 48 h post addition of doxycycline, only the unphosphorylated, fastermigrating form of pRB was present (Figure 3a) . The cell cycle inhibitory protein p27 Kip1 was strongly induced at 24 h, which coincided with hypophosphorylation of pRB and repression of cyclin A. To test whether p27
Kip1 induction was due to posttranslational regulation, we blocked protein synthesis with cycloheximide (CHX) and found that p27
Kip1 accumulation probably resulted from markedly increased protein stability (Figure 3b ). p27
Kip1 was found to copurify with CDK2, CDK4 and, to a lesser extent, with CDK6 in immunoprecipitation experiments with 6E2/p16 cells lacking transgenic p16
INK4A
( Figure 3c ). However, in cells expressing transgenic p16
INK4A , p27
Kip1 was displaced by p16 INK4A from CDK6 and CDK4 and increased amounts were associated with CDK2. The activity of CDK2, as measured using histone H1 as a substrate, was strongly reduced in presence of p16 INK4A , probably due to inhibition by bound p27 Kip1 . Thus, reconstitution of p16 INK4A in human CCRF-CEM leukemia cells appears to block the kinase activity of cyclin E/CDK2 by affecting the stability and distribution of p27 Kip1 .
Repression of c-Myc transcriptional activity correlates with activation of p107
We have recently shown that in CCRF-CEM leukemia cells, either c-Myc or cyclin D3 were sufficient to overcome G1 cell cycle arrest by glucocorticoid treatment. 24 This raised the question how p16
INK4A was able to induce cell cycle arrest in the same leukemia cells despite high levels of endogenous c-Myc ( Figure 2 ). To address this question in detail, we first studied the expression of two well-characterized c-Myc target genes, ODC 25 and PTMa 26 by Northern blot analysis. In p16
INK4A -expressing cells, ODC and PTMa expression was almost completely repressed (Figure 4a ), although at least PTMa was formerly shown to be a direct transcriptional target of c-Myc in these cells. 24 CDC25A, a major target of c-Myc that is essential for CDK2 activation was also repressed during p16
INK4A -induced cell cycle arrest (data not shown), suggesting Expression of p16 INK4A causes hypophosphorylation of pRB and repression of E2F-regulated target genes, but does not affect cyclin E, CDK2 or c-Myc expression. 1D2/p16, 6E2/p16 and 2C8 control cells were treated with 200 ng/ml doxycycline for 24 h and subjected to immunoblot (a) and Northern blot analysis (b). Protein levels were analyzed by antibodies against pRB, E2F-1, c-Myc, cyclin E, CDK2, and a-tubulin. mRNA steady-state levels were examined by Northern blotting using showed accumulation of its hypophosphorylated form (Figure 4b ). The pRB family member p107 is regulated by cyclin D/CDK4 28 and suppresses c-Myc activity in its hypophosphorylated form. 29 Activation of p107 might repress c-Myc transcriptional activity and explain, why p16
INK4A induces G1 cell cycle arrest in human leukemia cells despite the presence of highly expressed endogenous c-Myc.
Long-lasting cell cycle arrest by p16
INK4A causes morphologic changes, induction of T-cell-specific surface markers and repression of telomerase activity Thereafter, we determined whether the continuous presence of p16 INK4A caused only G1-arrest or also initiated differentiation. To this end, we determined morphologic criteria and expression of differentiation-associated surface proteins. When p16 INK4A expression was maintained for longer than 48 h, we observed significant changes in cell morphology, characterized by spikelike pseudopodia and enlarged cytoplasm (Figure 5a) . After 48 h, the expression of the T-cell-specific surface markers CD3 and CD4 increased 3.5-fold and over two-fold, respectively (Figure 5b ), elevations not seen in expression levels of other surface proteins such as CD25 and MHC II (data not shown). Telomerase activity, another hallmark of differentiated cells, was unaltered up to 48 h, but was repressed after 72 h of p16 INK4A expression (Figure 5c ).
p16
INK4A -induced cell cycle arrest is associated with high metabolic activity and cellular growth
To further characterize the G0/G1 status induced by p16
INK4A in CCRF-CEM leukemia cells, we assessed effects on cell proliferation, cell growth, mitochondrial function, overall protein synthesis and ATP production. As expected from the cell cycle analyses shown in Figure 1 , the number of p16
INK4A -expressing cells did not increase (Figure 6a ). However, cell growth, as reflected by cellular volume (Figure 6b ) and mitochondrial staining (Figure 6c ), was markedly increased: the mean cellular volume of p16
INK4A -expressing cells increased over two-fold, and fluorescence staining of mitochondrial membranes over three-fold compared to parental 2C8 control cells. Protein synthesis, as measured by incorporation of 35 S-methionine after 48 h of doxycycline treatment, was slightly increased compared to untreated controls (Figure 6d) . The most striking effect, however, was observed when we quantified cellular ATP: p16
INK4A expressing cells contained up to , pRB, p27 Kip1 , cyclin A and a-tubulin as loading control was monitored by immunoblot at the times indicated (a). Protein stability of p27
Kip1 during p16 INK4A expression was assessed by treatment of 6E2/p16 cells (36 h, 7200 ng doxycycline) with 100 mg/ml cycloheximide for 4 h. Samples for immunoblot analysis were taken at the indicated time points (b). p16 INK4A -expressing cells were cultured in the presence or absence of 200 ng/ ml doxycycline for 36 h. Protein levels of CDK2, CDK4 and CDK6 were determined by immunoblot. Kinase complexes were precipitated by antibodies against CDK2, CDK4, and CDK6, respectively, subjected to immunoblot analysis and histone H1 phosphorylation assay. Radioactive histone H1 (H1-phos) was detected by autoradiography, CDK-bound p27 Kip1 and p16 INK4A were determined by immunoblot analysis.
Figure 4
Inactivation of c-Myc transcriptional activity correlates with hypophosphorylation of p107. p16
INK4A
-expressing cells and 2C8 control cells were cultured for 24 h in the presence or absence of 200 ng/ml doxycycline and subjected to Northern blot (a) and immunoblot (b) analyses. mRNA expression was determined using 32 P-labeled cDNA probes for 18S RNA and the c-Myc target genes ODC and PTMa. Cellular protein levels of Max, Mad, p107, cyclin A and a-tubulin were assessed by immunoblot (b).
p16
INK4A uncouples growth from cell cycle MJ Ausserlechner et al eight-fold higher ATP levels than controls. The combined data suggest that G1-cell cycle arrest by p16
INK4A in leukemic T cells is associated with growth, protein synthesis, high metabolic activity and increased cellular ATP.
Discussion
In the study presented herein, we analyzed the effect of p16 INK4A reconstitution on human acute lymphoblastic CCRF-CEM T-cells that harbor a homozygous deletion of the INK4A locus. 22 Flow cytometric analysis of cell cycle progression and viability suggested that the CDK inhibitor caused arrest in the G1 phase that was stable for up to 72 h followed by increasing apoptosis over the next 24-48 h. As expected, p16
INK4A -induced cell cycle arrest was associated with pRB hypophosphorylation. However, c-Myc, cyclin E and CDK2 expression remained high, which was surprising because expression of these genes is considered downstream of pRB/E2F and reportedly interferes with cell cycle arrest in similar systems.
Continuous presence of cyclin E in p16
INK4A -expressing cells with functional pRB may be due to deregulated transcription and/or compromised protein degradation of this cyclin. Regulation of cyclin E transcription by c-Myc has been reported 15 and c-Myc is highly expressed in CCRF-CEM cells (Figure 2a ), but this may not explain our findings, since c-Myc Protracted cell cycle arrest by p16 INK4A causes morphologic changes, induction of T-cell-specific surface markers and repression of telomerase activity. Tetracycline-regulated p16
INK4A
-expressing cells were cultured in the absence or presence of 200 ng/ml doxycycline for 60 h and stained with a monoclonal antibody against human p16 INK4A (a, top) or Mayer's haemalum solution and 1% eosin (a, bottom). Surface expression of CD3 (b, left) and CD4 (b, right) was measured by FACS analysis at the times indicated. Shown is the mean of three independent experiments. Telomerase activity was measured at 48 and 72 h of doxycycline treatment using the TRAP protocol (c).
p16
INK4A uncouples growth from cell cycle MJ Ausserlechner et al seems to be transcriptionally inactive in p16 INK4A -expressing CCRF-CEM cells (see below). Cyclin E degradation is regulated by the human homologue of the archipelago (ago) gene, which binds to and targets cyclin E for degradation. 30 CCRF-CEM cells carry an arginine to cysteine missense mutation in codon 385 of the human ago gene, which might explain cyclin E accumulation in these cells. 30 The reasons for pRB-independent c-Myc and CDK2 expression are currently unknown. Given the deregulated expression of cyclin E in CCRF-CEM cells and its reported ability to shorten the G1 phase 31 and induce S-phase entry in fibroblasts expressing p16 INK4A , 20 the G1 arrest induced by p16
INK4A was unexpected. This finding might, however, be explained by the observation that cyclin E/CDK2 complexes were inactive in p16
INK4A -expressing CCRF-CEM cells (Figure 3c ), probably due to markedly increased stability of p27
Kip1 leading to accumulation of this kinase inhibitor. In addition, p16
INK4A caused an almost complete displacement of p27
Kip1 from CDK6 and, to a lesser extent, from CDK4, thereby further increasing the amount of p27
Kip1 available for cyclin E/CDK2 inactivation.
The other surprising finding was that p16
INK4A arrested CCRF-CEM cells in the presence of considerable levels of c-Myc. c-Myc has been described to abrogate p16 INK4A -induced cell cycle arrest when retrovirally transduced into rodent fibroblasts, 20 and prevented G1 arrest induced by glucocorticoids in CCRF-CEM cells. 24 The failure of c-Myc to prevent p16 INK4A -induced cell cycle arrest might be explained by its apparently compromised transcriptional activity (see Figure 2b) . c-Myc inactivation, in turn, might have been the consequence of p16
INK4A -mediated cyclin D/CDK4/6 inhibition with subsequent activation of the pRB family member p107 (Figure 4b ). This protein has been shown to form a specific complex with the Nterminus of c-Myc and strongly inhibits c-Myc transcriptional activity. 29, 32 Taken together, the data suggest that p16
INK4A
modulates the complex G1/S transition network in a way that confines the activity of two endogenous oncogenes that are generally thought to act downstream of cyclin D/CDK4/ p16 INK4A . Despite the deregulation of strong oncogenes, the leukemia cells are trapped in G1 by p16 INK4A . In addition to the molecular mechanisms leading to p16
INK4A -induced cell cycle INK4A uncouples growth from cell cycle MJ Ausserlechner et al arrest, we addressed possible effects of this tumor suppressor on cell morphology, expression of T-cell markers and telomerase, cell volume, mitochondrial staining, methionine incorporation and ATP synthesis as parameters for differentiation, growth and metabolic activity. The observed changes in morphology, the repression of telomerase activity and the induction of CD3 and CD4 expression may suggest initiation of differentiation, as has been described in aged fibroblasts that upregulate p16 INK4A 33, 34 and in JKB lymphoblastic leukemia cells expressing a temperature-regulated p16 INK4A mutant. 35 Perhaps as part of the above-mentioned differentiation process, p16
INK4A expression markedly increased cell growth, protein synthesis and ATP production. Two major regulatory networks control cellular growth: c-Myc as a critical transcription factor for essential ribosomal proteins, and the PI3-kinase (PI3K) as a catalyst of inositol-3-phosphate synthesis, thereby allowing activation of PDK1, PKB, and mTOR (for review see Ruggero and Pandolfi 36 ). Since growth regulation by c-Myc requires its transcriptional activation, 37, 38 which seems to be absent in p16 INK4A -arrested CCRF-CEM cells (Figure 2b ), this mechanism is not a likely candidate. These cells, however, harbor mutated PTEN, 39 which might result in deregulation of the PI3K/PKB axis and constitutive activation of PKB thereby causing a permanent growth signal. This notion is supported by the observation that addition of the PI3 K inhibitor Ly294002 repressed PKB phosphorylation and prevented growth of p16 INK4A -arrested leukemia cells (data not shown). Growth of p16
INK4A -arrested cells was further repressed by the mTOR inhibitor rapamycin (data not shown). The observed increased ATP levels in p16
INK4A -arrested cells might further activate mTOR signaling and protein synthesis, since mTOR acts as a cellular ATP sensor. 40 Thus, in this highly malignant ALL model, p16
acted as a tumor suppressor not only by repressing proliferation, but also by inducing a growth and differentiation process that finally leads to cell death in a majority of these leukemia cells.
Materials and methods
The details of this section are available online as Supplementary Information.
